📰 Michael Erman News
Page 73 - Michael Erman News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michael Erman. Real-time updates on events, politics, business and more.
November 2, 2021
CDC Director Rochelle Walensky must sign off on recommendations before the United States can begin administering the vaccine to children in the age group. The U.S. Food and Drug Administration granted emergency use authorization of the vaccine in 5-11 year olds on Friday.
November 1, 2021
By Ahmed Aboulenein and Alexandra Alper
October 29, 2021
The shot will not be immediately available to the age group. The U.S. Centers for Disease Control and Prevention still needs to advise on how the shot should be administered, which will be decided after a group of outside advisers discuss the plan on Tuesday.
October 29, 2021
The shot will not be immediately available to the age group. The U.S. Centers for Disease Control and Prevention still needs to advise on how the shot should be administered, which will be decided after a group of outside advisers discuss the plan on Tuesday.
October 29, 2021
The U.S. Food and Drug Administration on Friday authorized the Pfizer Inc and BioNTech SE coronavirus vaccine for children aged 5 to 11 years, making it the first COVID-19 shot for young children in the United States.
October 27, 2021
An authorization for that age group would be an important regulatory step toward reaching about 28 million children for inoculation, most of them back in school for in-person learning.
October 27, 2021
WASHINGTON (Reuters) - States have placed initial orders of COVID-19 vaccines for children and millions of doses will be shipped immediately as soon a...
October 27, 2021
WASHINGTON (Reuters) - States have placed initial orders of COVID-19 vaccines for children and millions of doses will be shipped immediately as soon a...
October 26, 2021
The U.S. Food and Drug Administration is considering authorizing a COVID-19 vaccine for children aged 5 to 11. The vaccine from Pfizer Inc and BioNTech SE has been available in the United States to kids aged 12 to 15 since May.
October 26, 2021
An authorization for that age group would be would be an important regulatory step toward reaching about 28 million children for inoculation, most of them back in school for in-person learning.